Value Sense
HSCS
Heart Test Laboratories, Inc. (HSCS)
Last Price$2.95.0%
Market Cap$2,541.3M
LTM Return on Assets (ROA)
(51,827.8%)
5Y avg
(3,579.5%)
Medical - Devices industry median
(27.1%)
Stock quality & Intrinsic value
5/10
114.5% undervalued
HSCS
is 11,448.4% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Heart Test Laboratories, Inc. Return on Assets (ROA)

Annual
Quarterly
LTM
Industry median
Company stand-alone
HSCS
Healthcare
Crunching data... Almost there!
Apr'20Apr'21Apr'22Apr'23Apr'24
Return on Assets (ROA)
(194.9%)
(126.3%)
(240.4%)
(236.4%)
(103.3%)
HSCS
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for HSCS and see if it's the right time to invest.
Dive in

Heart Test Laboratories, Inc. (HSCS) Return on Assets (ROA) comparison analysis

General

LTM Return on Assets (ROA)

OTHER METRICS

Company name

Revenue growth

EPS growth

Net Income margin

Heart Test Laboratories, Inc. logo
Heart Test Laboratories, Inc.HSCS
(51,827.8%)
261.2%
(99.7%)
(35,511.9%)
Median Peer Set
6.1%
4.2%
59.2%
12.5%
Edwards Lifesciences Corporation logo
Edwards Lifesciences CorporationEW
31.8%
(9.4%)
202.2%
76.7%
Abbott Laboratories logo
Abbott LaboratoriesABT
17.2%
4.6%
134.5%
31.9%
Insulet Corporation logo
Insulet CorporationPODD
13.7%
22.1%
101.7%
20.2%
DexCom, Inc. logo
DexCom, Inc.DXCM
9.0%
11.3%
(1.4%)
14.3%
Stryker Corporation logo
Stryker CorporationSYK
6.9%
10.2%
(5.8%)
13.2%
Boston Scientific Corporation logo
Boston Scientific CorporationBSX
5.4%
17.6%
16.7%
11.1%
Medtronic plc logo
Medtronic plcMDT
4.8%
3.6%
(2.1%)
11.4%
STERIS plc logo
STERIS plcSTE
4.6%
3.6%
257.9%
7.4%
Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc.ZBH
4.2%
3.8%
(9.4%)
11.8%
Koninklijke Philips N.V. logo
Koninklijke Philips N.V.PHG
(2.7%)
(0.8%)
122.5%
(3.9%)

HSCS key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Apr'20Apr'21Apr'22Apr'23Apr'24
Revenue
% growth
0.1
0.0%
0.0
(60.1%)
0.0
(43.9%)
0.0
(64.2%)
0.0
261.2%
Cost of Goods Sold (COGS)0.00.00.00.00.0
Gross Profit
% margin
0.0
27.6%
0.0
58.3%
0.0
45.1%
0.0
45.7%
0.0
67.3%
Operating Expenses3.82.64.76.16.3
Research & Development Expenses (R&D)2.01.73.02.52.9
Selling, General & Administrative Expenses (SG&A)1.80.91.73.73.4
Operating Income
% margin
(3.8)
(5,949.0%)
(2.6)
(10,030.2%)
(4.7)
(32,765.6%)
(6.1)
(118,698.3%)
(6.3)
(33,902.0%)
Interest Income0.00.10.40.20.0
Interest Expense0.00.10.40.20.4
Pre-tax Income(3.8)(2.5)(4.8)(6.4)(6.6)
Income Tax
% effective tax rate
0.0
(0.6%)
0.1
(5.3%)
(0.3)
5.2%
484.5
(7,624.8%)
0.0
0.0%
Net Income
% margin
(3.8)
(5,973.4%)
(2.6)
(10,081.1%)
(4.6)
(31,851.8%)
(490.9)
(9,531,151.3%)
(6.6)
(35,511.9%)
EPS(115.69)(77.89)(137.94)(6,173.88)(18.74)
Diluted EPS(115.69)(77.89)(137.94)(6,173.88)(18.74)
EBITDA
% margin
(3.7)
(5,834.2%)
(2.3)
(8,928.7%)
(4.4)
(30,822.2%)
(6.1)
(118,139.8%)
(6.2)
(33,096.7%)

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Heart Test Laboratories, Inc.'s Return on Assets (ROA)?

As of today, Microsoft Corp's last 12-month Return on Assets (ROA) is (51,827.8%), based on the financial report for Oct 31, 2024 (Q4’2024). The average annual Return on Assets (ROA) for Heart Test Laboratories, Inc. have been (3,579.5%) over the past three years, and (2,684.6%) over the past five years.

2) Is Heart Test Laboratories, Inc.'s Return on Assets (ROA) Good?

As of today, Heart Test Laboratories, Inc.'s Return on Assets (ROA) is (51,827.8%), which is lower than industry median of (27.1%). It indicates that Heart Test Laboratories, Inc.'s Return on Assets (ROA) is Bad.

3) How does Heart Test Laboratories, Inc.'s Return on Assets (ROA) compare to its peers?

As of today, Heart Test Laboratories, Inc.'s Return on Assets (ROA) is (51,827.8%), which is lower than peer median of 6.1%. The list of peers includes EW, ABT, PODD, DXCM, SYK, BSX, MDT, STE, ZBH, PHG.